<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">30465590</PMID>
      <DateCompleted>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>26</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2020</Year>
        <Month>03</Month>
        <Day>09</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">2175-8239</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>41</Volume>
            <Issue>2</Issue>
            <PubDate>
              <Year>2019</Year>
              <Season>Apr-Jun</Season>
            </PubDate>
          </JournalIssue>
          <Title>Jornal brasileiro de nefrologia : 'orgao oficial de Sociedades Brasileira e Latino-Americana de Nefrologia</Title>
          <ISOAbbreviation>J Bras Nefrol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Pediatric lupus nephritis.</ArticleTitle>
        <Pagination>
          <StartPage>252</StartPage>
          <EndPage>265</EndPage>
          <MedlinePgn>252-265</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1590/2175-8239-JBN-2018-0097</ELocationID>
        <Abstract>
          <AbstractText>Involvement of the kidneys by lupus nephritis (LN) is one of the most severe clinical manifestations seen in individuals with systemic lupus erythematosus (SLE). LN is more frequent and severe in pediatric patients and has been associated with higher morbidity and mortality rates. This narrative review aimed to describe the general aspects of LN and its particularities when affecting children and adolescents, while focusing on the disease's etiopathogenesis, clinical manifestations, renal tissue alterations, and treatment options.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Pinheiro</LastName>
            <ForeName>Sergio Veloso Brant</ForeName>
            <Initials>SVB</Initials>
            <AffiliationInfo>
              <Affiliation>Universidade Federal de Minas Gerais, Hospital das Clínicas, Unidade de Nefrologia Pediátrica, Belo Horizonte, MG, Brasil.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Dias</LastName>
            <ForeName>Raphael Figuiredo</ForeName>
            <Initials>RF</Initials>
            <AffiliationInfo>
              <Affiliation>Universidade Federal de Minas Gerais, Hospital das Clínicas, Unidade de Nefrologia Pediátrica, Belo Horizonte, MG, Brasil.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Fabiano</LastName>
            <ForeName>Rafaela Cabral Gonçalves</ForeName>
            <Initials>RCG</Initials>
            <AffiliationInfo>
              <Affiliation>Universidade Federal de Minas Gerais, Hospital das Clínicas, Unidade de Nefrologia Pediátrica, Belo Horizonte, MG, Brasil.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Araujo</LastName>
            <ForeName>Stanley de Almeida</ForeName>
            <Initials>SA</Initials>
            <AffiliationInfo>
              <Affiliation>Universidade Federal de Minas Gerais, Hospital das Clínicas, Unidade de Nefrologia Pediátrica, Belo Horizonte, MG, Brasil.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Silva</LastName>
            <ForeName>Ana Cristina Simões E</ForeName>
            <Initials>ACSE</Initials>
            <Identifier Source="ORCID">0000-0001-9222-3882</Identifier>
            <AffiliationInfo>
              <Affiliation>Universidade Federal de Minas Gerais, Hospital das Clínicas, Unidade de Nefrologia Pediátrica, Belo Horizonte, MG, Brasil.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <Language>por</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2018</Year>
          <Month>11</Month>
          <Day>14</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>J Bras Nefrol</MedlineTA>
        <NlmUniqueID>9426946</NlmUniqueID>
        <ISSNLinking>0101-2800</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName>
          <QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>
          <QualifierName UI="Q000652" MajorTopicYN="N">urine</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D042241" MajorTopicYN="N">Early Diagnosis</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008181" MajorTopicYN="N">Lupus Nephritis</DescriptorName>
          <QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
          <QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
          <QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
          <QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D035583" MajorTopicYN="N">Rare Diseases</DescriptorName>
          <QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
          <QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
          <QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
          <QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2018</Year>
          <Month>4</Month>
          <Day>24</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2018</Year>
          <Month>9</Month>
          <Day>5</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>11</Month>
          <Day>23</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>27</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>11</Month>
          <Day>23</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">30465590</ArticleId>
        <ArticleId IdType="pmc">PMC6699445</ArticleId>
        <ArticleId IdType="doi">10.1590/2175-8239-JBN-2018-0097</ArticleId>
        <ArticleId IdType="pii">S0101-28002018005041102</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Levy DM, Kamphuis S. Systemic lupus erythematosus in children and
adolescents. Pediatr Clin North Am 2012;59:345-64.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3348509</ArticleId>
            <ArticleId IdType="pubmed">22560574</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Levy DM, Kamphuis S. Systemic lupus erythematosus in children and
adolescents. Pediatr Clin North Am. 2012;59:345–364.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3348509</ArticleId>
            <ArticleId IdType="pubmed">22560574</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bao L, Cunningham PN, Quigg RJ. Complement in Lupus Nephritis: New
Perspectives. Kidney Dis (Basel) 2015;1:91-9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4934819</ArticleId>
            <ArticleId IdType="pubmed">27536669</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bao L, Cunningham PN, Quigg RJ. Complement in Lupus Nephritis: New Perspectives. Kidney Dis (Basel) 2015;1:91–99.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4934819</ArticleId>
            <ArticleId IdType="pubmed">27536669</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Davidson A. What is damaging the kidney in lupus nephritis? Nat Rev
Rheumatol 2016;12:143-53.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4820834</ArticleId>
            <ArticleId IdType="pubmed">26581344</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Davidson A. What is damaging the kidney in lupus nephritis? Nat Rev Rheumatol. 2016;12:143–153.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4820834</ArticleId>
            <ArticleId IdType="pubmed">26581344</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mohan C, Putterman C. Genetics and pathogenesis of systemic lupus
erythematosus and lupus nephritis. Nat Rev Rheumatol
2015;11:329-41.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25825084</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mohan C, Putterman C. Genetics and pathogenesis of systemic lupus erythematosus and
lupus nephritis. Nat Rev Rheumatol. 2015;11:329–341.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25825084</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sinha R, Raut S. Pediatric lupus nephritis: Management update. World
J Nephrol 2014;3:16-23.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4023399</ArticleId>
            <ArticleId IdType="pubmed">24868499</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sinha R, Raut S. Pediatric lupus nephritis: Management update. World J Nephrol. 2014;3:16–23.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4023399</ArticleId>
            <ArticleId IdType="pubmed">24868499</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Malattia C, Martini A. Paediatric-onset systemic lupus
erythematosus. Best Pract Res Clin Rheumatol 2013;27:351-62.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24238692</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Malattia C, Martini A. Paediatric-onset systemic lupus erythematosus. Best Pract Res Clin Rheumatol. 2013;27:351–362.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24238692</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Stojan G, Petri M. Epidemiology of systemic lupus erythematosus: an
update. Curr Opin Rheumatol 2018;30:144-50.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6026543</ArticleId>
            <ArticleId IdType="pubmed">29251660</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Stojan G, Petri M. Epidemiology of systemic lupus erythematosus: an
update. Curr Opin Rheumatol. 2018;30:144–150.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6026543</ArticleId>
            <ArticleId IdType="pubmed">29251660</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vilar MJP, Rodrigues JM, Sato EI. Incidência de lúpus eritematoso
sistêmico em Natal, RN - Brasil. Rev Bras Reumatol
2003;43:343-6.</Citation>
        </Reference>
        <Reference>
          <Citation>Vilar MJP, Rodrigues JM, Sato EI. Incidência de lúpus eritematoso sistêmico em Natal, RN -
Brasil. Rev Bras Reumatol. 2003;43:343–346.</Citation>
        </Reference>
        <Reference>
          <Citation>Wenderfer SE, Ruth NM, Brunner HI. Advances in the care of children
with lupus nephritis. Pediatr Res 2017;81:406-14.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27855151</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wenderfer SE, Ruth NM, Brunner HI. Advances in the care of children with lupus
nephritis. Pediatr Res. 2017;81:406–414.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27855151</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kamphuis S, Silverman ED. Prevalence and burden of pediatric-onset
systemic lúpus erythematosus. Nat Rev Rheumatol 2010;6:538-46.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20683438</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kamphuis S, Silverman ED. Prevalence and burden of pediatric-onset systemic lúpus
erythematosus. Nat Rev Rheumatol. 2010;6:538–546.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20683438</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yu Y, Du L, Pan J, Zheng J, Chen A, Chen L. A 10-year retrospective
study of neonatal lupus erythematous in China. Asian Pac J Allergy Immunol
2016;34:174-8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27007840</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yu Y, Du L, Pan J, Zheng J, Chen A, Chen L. A 10-year retrospective study of neonatal lupus erythematous in
China. Asian Pac J Allergy Immunol. 2016;34:174–178.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27007840</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Klein-Gitelman MS. Neonatal Lupus: What we have learned and current
approaches to care. Curr Rheumatol Rep 2016;18:60.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27475948</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Klein-Gitelman MS. Neonatal Lupus: What we have learned and current approaches to
care. Curr Rheumatol Rep. 2016;18:60–60.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27475948</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gomes RC, Silva MF, Kozu K, Bonfá E, Pereira RM, Terreri MT, et al.
Features of 847 Childhood-Onset Systemic Lupus Erythematosus Patients in Three
Age Groups at Diagnosis: A Brazilian Multicenter Study. Arthritis Care Res
(Hoboken) 2016;68:1736-41.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27014968</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gomes RC, Silva MF, Kozu K, Bonfá E, Pereira RM, Terreri MT, et al.  Features of 847 Childhood-Onset Systemic Lupus Erythematosus
Patients in Three Age Groups at Diagnosis: A Brazilian Multicenter
Study. Arthritis Care Res (Hoboken) 2016;68:1736–1741.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27014968</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Silva CA, Avcin T, Brunner HI. Taxonomy for systemic lupus
erythematosus with onset before adulthood. Arthritis Care Res (Hoboken)
2012;64:1787-93.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3463746</ArticleId>
            <ArticleId IdType="pubmed">22730317</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Silva CA, Avcin T, Brunner HI. Taxonomy for systemic lupus erythematosus with onset before
adulthood. Arthritis Care Res (Hoboken) 2012;64:1787–1793.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3463746</ArticleId>
            <ArticleId IdType="pubmed">22730317</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Oliver JE, Silman AJ. Why are women predisposed to autoimmune
rheumatic diseases? Arthritis Res Ther 2009;11:252.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2787267</ArticleId>
            <ArticleId IdType="pubmed">19863777</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Oliver JE, Silman AJ. Why are women predisposed to autoimmune rheumatic
diseases. Arthritis Res Ther. 2009;11:252–252.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2787267</ArticleId>
            <ArticleId IdType="pubmed">19863777</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pereira MV, Revelo MP, Bambirra EA. Lupus nephropathy in childhood:
morphologic analysis of 18 cases. J Pediatr (Rio J)
1996;72:32-4.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14688972</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pereira MV, Revelo MP, Bambirra EA. Lupus nephropathy in childhood: morphologic analysis of 18
cases. J Pediatr (Rio J) 1996;72:32–34.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14688972</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Aggarwal A, Srivastava P. Childhood onset systemic lupus
erythematosus: how is it different from adult SLE? Int J Rheumatic Dis
2015;18:182-91.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24965742</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Aggarwal A, Srivastava P. Childhood onset systemic lupus erythematosus: how is it different
from adult SLE? Int J Rheumatic Dis. 2015;18:182–191.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24965742</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Almaani S, Meara A, Rovin BH. Update on Lupus Nephritis. Clin J Am
Soc Nephrol 2017;12:825-35.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5477208</ArticleId>
            <ArticleId IdType="pubmed">27821390</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Almaani S, Meara A, Rovin BH. Update on Lupus Nephritis. Clin J Am Soc Nephrol. 2017;12:825–835.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5477208</ArticleId>
            <ArticleId IdType="pubmed">27821390</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hiraki LT, Benseler SM, Tyrrell PN, Harvey E, Hebert D, Silverman
ED. Ethnic differences in pediatric systemic lúpus erythematosus. J Rheumatol
2009;36:2539-46.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19833755</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hiraki LT, Benseler SM, Tyrrell PN, Harvey E, Hebert D, Silverman ED. Ethnic differences in pediatric systemic lúpus
erythematosus. J Rheumatol. 2009;36:2539–2546.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19833755</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lewandowski LB, Schanberg LE, Thielman N, Phuti A, Kalla AA, Okpechi
I, et al. Severe disease presentation and poor outcomes among pediatric systemic
lupus erythematosus patients in South Africa. Lupus
2017;26:186-94.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5290292</ArticleId>
            <ArticleId IdType="pubmed">27488473</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lewandowski LB, Schanberg LE, Thielman N, Phuti A, Kalla AA, Okpechi I, et al.  Severe disease presentation and poor outcomes among pediatric
systemic lupus erythematosus patients in South Africa. Lupus. 2017;26:186–194.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5290292</ArticleId>
            <ArticleId IdType="pubmed">27488473</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bennett M, Brunner HI. Biomarkers and updates on pediatrics lupus
nephritis. Rheum Dis Clin North Am 2013;39:833-53.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4980821</ArticleId>
            <ArticleId IdType="pubmed">24182857</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bennett M, Brunner HI. Biomarkers and updates on pediatrics lupus
nephritis. Rheum Dis Clin North Am. 2013;39:833–853.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4980821</ArticleId>
            <ArticleId IdType="pubmed">24182857</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Muñoz LE, Lauber K, Schiller M, Manfredi AA, Herrmann M. The role of
defective clearance of apoptotic cells in systemic autoimmunity. Nat Rev
Rheumatol 2010;6:280-9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20431553</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Muñoz LE, Lauber K, Schiller M, Manfredi AA, Herrmann M. The role of defective clearance of apoptotic cells in systemic
autoimmunity. Nat Rev Rheumatol. 2010;6:280–289.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20431553</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nowling TK, Gilkeson GS. Mechanisms of tissue injury in lupus
nephritis. Arthritis Res Ther 2011;13:250.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3334648</ArticleId>
            <ArticleId IdType="pubmed">22192660</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nowling TK, Gilkeson GS. Mechanisms of tissue injury in lupus nephritis. Arthritis Res Ther. 2011;13:250–250.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3334648</ArticleId>
            <ArticleId IdType="pubmed">22192660</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Anders HJ, Fogo AB. Immunopathology of lupus nephritis. Semin
Immunopathol 2014;36:443-59.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24402709</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Anders HJ, Fogo AB. Immunopathology of lupus nephritis. Semin Immunopathol. 2014;36:443–459.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24402709</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Flores-Mendoza G, Sansón SP, Rodríguez-Castro S, Crispín JC, Rosetti
F. Mechanisms of Tissue Injury in Lupus Nephritis. Trends Mol Med
2018;24:364-78.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29526595</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Flores-Mendoza G, Sansón SP, Rodríguez-Castro S, Crispín JC, Rosetti F. Mechanisms of Tissue Injury in Lupus Nephritis. Trends Mol Med. 2018;24:364–378.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29526595</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Anders HJ. Pseudoviral immunity - a novel concept for lupus. Trends
Mol Med 2009;15:553-61.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19896418</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Anders HJ. Pseudoviral immunity - a novel concept for lupus. Trends Mol Med. 2009;15:553–561.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19896418</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vachvanichsanong P, McNeil E. Pediatric lupus nephritis: more
options, more chances? Lupus 2013;22:545-53.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23629826</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vachvanichsanong P, McNeil E. Pediatric lupus nephritis: more options, more
chances? Lupus. 2013;22:545–553.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23629826</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bernatsky S, Boivin JF, Joseph L, Manzi S, Ginzler E, Gladman DD, et
al. Mortality in systemic lupus erythematosus. Arthritis Rheum
2006;54:2550-7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16868977</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bernatsky S, Boivin JF, Joseph L, Manzi S, Ginzler E, Gladman DD, et al.  Mortality in systemic lupus erythematosus. Arthritis Rheum. 2006;54:2550–2557.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16868977</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Petri M, Orbai AM, Alarcón GS, Gordon C, Merrill JT, Fortin PR, et
al. Derivation and Validation of the Systemic Lupus International Collaborating
Clinics Classification Criteria for Systemic Lupus Erythematosus. Arthritis
Rheum 2012;64:2677-86.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3409311</ArticleId>
            <ArticleId IdType="pubmed">22553077</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Petri M, Orbai AM, Alarcón GS, Gordon C, Merrill JT, Fortin PR, et al.  Derivation and Validation of the Systemic Lupus International
Collaborating Clinics Classification Criteria for Systemic Lupus
Erythematosus. Arthritis Rheum. 2012;64:2677–2686.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3409311</ArticleId>
            <ArticleId IdType="pubmed">22553077</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hahn BH, McMahon MA, Wilkinson A, Wallace WD, Daikh DI, Fitzgerald
JD, et al.; American College of Rheumatology. American College of Rheumatology
guidelines for screening, treatment, and management of lupus nephritis.
Arthritis Care Res (Hoboken) 2012;64:797-808.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3437757</ArticleId>
            <ArticleId IdType="pubmed">22556106</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hahn BH, McMahon MA, Wilkinson A, Wallace WD, Daikh DI, Fitzgerald JD, et al. American College of Rheumatology  American College of Rheumatology guidelines for screening,
treatment, and management of lupus nephritis. Arthritis Care Res (Hoboken) 2012;64:797–808.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3437757</ArticleId>
            <ArticleId IdType="pubmed">22556106</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Anders HJ, Weening JJ. Kidney disease in lupus is not always 'lupus
nephritis'. Arthritis Res Ther 2013;15:108.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3672669</ArticleId>
            <ArticleId IdType="pubmed">23448342</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Anders HJ, Weening JJ. Kidney disease in lupus is not always 'lupus
nephritis'. Arthritis Res Ther. 2013;15:108–108.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3672669</ArticleId>
            <ArticleId IdType="pubmed">23448342</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Soliman S, Mohan C. Lupus nephritis biomarkers. Clin Immunol
2017;185:10-20.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27498110</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Soliman S, Mohan C. Lupus nephritis biomarkers. Clin Immunol. 2017;185:10–20.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27498110</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Thurman JM, Nester CM. All things complement. Clin J Am Soc Nephrol
2016;11:1856-66.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5053787</ArticleId>
            <ArticleId IdType="pubmed">27340286</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Thurman JM, Nester CM. All things complement. Clin J Am Soc Nephrol. 2016;11:1856–1866.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5053787</ArticleId>
            <ArticleId IdType="pubmed">27340286</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yin Y, Wu X, Shan G, Zhang X. Diagnostic value of serum anti-C1q
antibodies in patients with lupus nephritis: a meta-analysis. Lupus
2012;21:1088-97.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22777943</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yin Y, Wu X, Shan G, Zhang X. Diagnostic value of serum anti-C1q antibodies in patients with
lupus nephritis: a meta-analysis. Lupus. 2012;21:1088–1097.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22777943</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Eggleton P, Ukoumunne OC, Cottrell I, Khan A, Maqsood S, Thornes J,
et al. Autoantibodies against C1q as a diagnostic measure of Lupus Nephritis:
Systematic review and meta-analysis. J Clin Cell Immunol
2014;5:210.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4062947</ArticleId>
            <ArticleId IdType="pubmed">24955287</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Eggleton P, Ukoumunne OC, Cottrell I, Khan A, Maqsood S, Thornes J, et al.  Autoantibodies against C1q as a diagnostic measure of Lupus
Nephritis: Systematic review and meta-analysis. J Clin Cell Immunol. 2014;5:210–210.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4062947</ArticleId>
            <ArticleId IdType="pubmed">24955287</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Goilav B, Putterman C, Rubinstein TB. Biomarkers for kidney
involvement in pediatric lupus. Biomark Med 2015;9:529-43.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4489544</ArticleId>
            <ArticleId IdType="pubmed">26079958</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Goilav B, Putterman C, Rubinstein TB. Biomarkers for kidney involvement in pediatric
lupus. Biomark Med. 2015;9:529–543.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4489544</ArticleId>
            <ArticleId IdType="pubmed">26079958</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Qi S, Chen Q, Xu D, Xie N, Dai Y. Clinical application of protein
biomarkers in lupus erythematosus and lupus nephritis. Lupus 2018;27:1582-90.
DOI: 10.1177/0961203318773643</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29720035</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Qi S, Chen Q, Xu D, Xie N, Dai Y. Clinical application of protein biomarkers in lupus erythematosus
and lupus nephritis. Lupus. 2018;27:1582–1590. doi: 10.1177/0961203318773643.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1177/0961203318773643</ArticleId>
            <ArticleId IdType="pubmed">29720035</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Houssiau FA, Vasconcelos C, D'Cruz D, Sebastiani GD, de Ramon
Garrido E, Danieli MG, et al. Early response to immunosuppressive therapy
predicts good renal outcome in lupus nephritis: lessons from long-term follow-up
of patients in the Euro-Lupus Nephritis Trial. Arthritis Rheum
2004;50:3934-40.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15593207</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Houssiau FA, Vasconcelos C, D'Cruz D, Sebastiani GD, de Ramon Garrido E, Danieli MG, et al.  Early response to immunosuppressive therapy predicts good renal
outcome in lupus nephritis: lessons from long-term follow-up of patients in
the Euro-Lupus Nephritis Trial. Arthritis Rheum. 2004;50:3934–3940.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15593207</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Moreno JA, Yuste C, Gutiérrez E, Sevillano ÁM, Rubio-Navarro A,
Amaro-Villalobos JM, et al. Haematuria as a risk factor for chronic kidney
disease progression in glomerular diseases: A review. Pediatr Nephrol
2016;31:523-33.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25980470</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Moreno JA, Yuste C, Gutiérrez E, Sevillano ÁM, Rubio-Navarro A, Amaro-Villalobos JM, et al.  Haematuria as a risk factor for chronic kidney disease
progression in glomerular diseases: A review. Pediatr Nephrol. 2016;31:523–533.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25980470</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Klumb EM, Silva CA, Lanna CCD, Sato EI, Borba EF, Brenol JCT, et al.
Consensus of the Brazilian Society of Rheumatology for the diagnosis, management
and treatment of lupus nephritis. Rev Bras Reumatol
2015;55:1-21.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25595733</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Klumb EM, Silva CA, Lanna CCD, Sato EI, Borba EF, Brenol JCT, et al.  Consensus of the Brazilian Society of Rheumatology for the
diagnosis, management and treatment of lupus nephritis. Rev Bras Reumatol. 2015;55:1–21.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25595733</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fathallah-Shaykh SA. Proteinuria and progression of pediatric
chronic kidney disease: lessons from recent clinical studies. Pediatr Nephrol
2017;32:743-51.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27350622</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fathallah-Shaykh SA. Proteinuria and progression of pediatric chronic kidney disease:
lessons from recent clinical studies. Pediatr Nephrol. 2017;32:743–751.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27350622</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Brunner HI, Bennett MR, Mina R, Suzuki M, Petri M, Kiani AN, et al.
Association of noninvasively measured renal protein biomarkers with histologic
features of lupus nephritis. Arthritis Rheum 2012;64:2687-97.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3381849</ArticleId>
            <ArticleId IdType="pubmed">22328173</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Brunner HI, Bennett MR, Mina R, Suzuki M, Petri M, Kiani AN, et al.  Association of noninvasively measured renal protein biomarkers
with histologic features of lupus nephritis. Arthritis Rheum. 2012;64:2687–2697.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3381849</ArticleId>
            <ArticleId IdType="pubmed">22328173</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Smith EM, Jorgensen AL, Midgley A, Oni L, Goilav B, Putterman C, et
al. International validation of a urinary biomarker panel for identification of
active lupus nephritis in children. Pediatr Nephrol
2017;32:283-95.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5203828</ArticleId>
            <ArticleId IdType="pubmed">27590021</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Smith EM, Jorgensen AL, Midgley A, Oni L, Goilav B, Putterman C, et al.  International validation of a urinary biomarker panel for
identification of active lupus nephritis in children. Pediatr Nephrol. 2017;32:283–295.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5203828</ArticleId>
            <ArticleId IdType="pubmed">27590021</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Brunner HI, Bennett MR, Abulaban K, Klein-Gitelman MS, O'Neil KM,
Tucker L, et al. Development of a novel renal activity index of lupus nephritis
in children and young adults. Arthritis Care Res (Hoboken)
2016;68:1003-11.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4834060</ArticleId>
            <ArticleId IdType="pubmed">26473509</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Brunner HI, Bennett MR, Abulaban K, Klein-Gitelman MS, O'Neil KM, Tucker L, et al.  Development of a novel renal activity index of lupus nephritis in
children and young adults. Arthritis Care Res (Hoboken) 2016;68:1003–1011.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4834060</ArticleId>
            <ArticleId IdType="pubmed">26473509</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kashgarian M. Clinical significance of renal biopsy in subacute
lupus erythematosus. Transfusion Sci 1992;13:135-44.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10148125</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kashgarian M. Clinical significance of renal biopsy in subacute lupus
erythematosus. Transfusion Sci. 1992;13:135–144.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10148125</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sprangers B, Monahan M, Appel GB. Diagnosis and treatment of lupus
nephritis flares--an update. Nat Rev Nephrol 2012;8:709-17.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23147758</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sprangers B, Monahan M, Appel GB. Diagnosis and treatment of lupus nephritis flares--an
update. Nat Rev Nephrol. 2012;8:709–717.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23147758</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zickert A, Sundelin B, Svenungsson E, Gunnarsson I. Role of early
repeated renal biopsies in lupus nephritis. Lupus Sci Med
2014;1:e000018.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4213828</ArticleId>
            <ArticleId IdType="pubmed">25379188</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zickert A, Sundelin B, Svenungsson E, Gunnarsson I. Role of early repeated renal biopsies in lupus
nephritis. Lupus Sci Med. 2014;1:e000018. </Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4213828</ArticleId>
            <ArticleId IdType="pubmed">25379188</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wilhelmus S, Alpers CE, Cook HT, Ferrario F, Fogo AB, Haas M, et al.
The revisited classification of GN in SLE at 10 years: time to re-evaluate
histopathologic lesions. J Am Soc Nephrol 2015;26:2938-46.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4657848</ArticleId>
            <ArticleId IdType="pubmed">26152271</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wilhelmus S, Alpers CE, Cook HT, Ferrario F, Fogo AB, Haas M, et al.  The revisited classification of GN in SLE at 10 years: time to
re-evaluate histopathologic lesions. J Am Soc Nephrol. 2015;26:2938–2946.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4657848</ArticleId>
            <ArticleId IdType="pubmed">26152271</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Weening JJ, D'Agati VD, Schwartz MM, Seshan SV, Alpers CE, Appel GB,
et al. The classification of glomerulonephritis in systemic lupus erythematosus
revisited. J Am Soc Nephrol 2004;15:241-50.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14747370</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Weening JJ, D'Agati VD, Schwartz MM, Seshan SV, Alpers CE, Appel GB, et al.  The classification of glomerulonephritis in systemic lupus
erythematosus revisited. J Am Soc Nephrol. 2004;15:241–250.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14747370</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Weening JJ, D'Agati VD, Schwartz MM, Seshan SV, Alpers CE, Appel GB,
et al.; International Society of Nephrology Working Group on the Classification
of Lupus Nephritis; Renal Pathology Society Working Group on the Classification
of Lupus Nephritis. The classification of glomerulonephritis in systemic lupus
erythematosus revisited. Kidney Int 2004;65:521-30.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14717922</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Weening JJ, D'Agati VD, Schwartz MM, Seshan SV, Alpers CE, Appel GB, et al. International Society of Nephrology Working Group on the
Classification of Lupus NephritisRenal Pathology Society Working Group
on the Classification of Lupus Nephritis  The classification of glomerulonephritis in systemic lupus
erythematosus revisited. Kidney Int. 2004;65:521–530.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14717922</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bajema IM, Wilhelmus S, Alpers CE, Bruijn JA, Colvin RB, Cook HT, et
al. Revision of the International Society of Nephrology/Renal Pathology Society
classification for lupus nephritis: clarification of definitions, and modified
National Institutes of Health activity and chronicity indices. Kidney Int
2018;93:789-96. DOI: 10.1016/j.kint.2017.11.023</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29459092</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bajema IM, Wilhelmus S, Alpers CE, Bruijn JA, Colvin RB, Cook HT, et al.  Revision of the International Society of Nephrology/Renal
Pathology Society classification for lupus nephritis: clarification of
definitions, and modified National Institutes of Health activity and
chronicity indices. Kidney Int. 2018;93:789–796. doi: 10.1016/j.kint.2017.11.023.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.kint.2017.11.023</ArticleId>
            <ArticleId IdType="pubmed">29459092</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang Y, Yu F, Song D, Wang SX, Zhao MH. Podocyte involvement in
lupus nephritis based onthe 2003 ISN/RPS system: a large cohort study from a
single centre. Rheumatology (Oxford) 2014;53:1235-44.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24599917</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang Y, Yu F, Song D, Wang SX, Zhao MH. Podocyte involvement in lupus nephritis based onthe 2003 ISN/RPS
system: a large cohort study from a single centre. Rheumatology (Oxford) 2014;53:1235–1244.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24599917</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rich SA. Human lupus inclusions and interferon. Science
1981;213:772-5.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">6166984</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rich SA. Human lupus inclusions and interferon. Science. 1981;213:772–775.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">6166984</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wu LH, Yu F, Tan Y, Qu Z, Chen MH, Wang SX, et al. Inclusion of
renal vascular lesions in the 2003 ISN/RPS system for classifying lupus
nephritis improves renal outcome predictions. Kidney Int
2013;83:715-23.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23302713</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wu LH, Yu F, Tan Y, Qu Z, Chen MH, Wang SX, et al.  Inclusion of renal vascular lesions in the 2003 ISN/RPS system
for classifying lupus nephritis improves renal outcome
predictions. Kidney Int. 2013;83:715–723.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23302713</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Barber C, Herzenberg A, Aghdassi E, Su J, Lou W, Qian G, et al.
Evaluation of clinical outcomes and renal vascular pathology among patients with
lupus. Clin J Am Soc Nephrol 2012;7:757-64.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3338275</ArticleId>
            <ArticleId IdType="pubmed">22442181</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Barber C, Herzenberg A, Aghdassi E, Su J, Lou W, Qian G, et al.  Evaluation of clinical outcomes and renal vascular pathology
among patients with lupus. Clin J Am Soc Nephrol. 2012;7:757–764.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3338275</ArticleId>
            <ArticleId IdType="pubmed">22442181</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Goodship TH, Cook HT, Fakhouri F, Fervenza FC, Frémeaux-Bacchi V,
Kavanagh D, et al.; Conference Participants. Atypical hemolytic uremic syndrome
and C3 glomerulopathy: conclusions from a "Kidney Disease: Improving Global
Outcomes" (KDIGO) Controversies Conference. Kidney Int
2017;91:539-51.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27989322</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Goodship TH, Cook HT, Fakhouri F, Fervenza FC, Frémeaux-Bacchi V, Kavanagh D, et al. Conference Participants  Atypical hemolytic uremic syndrome and C3 glomerulopathy:
conclusions from a "Kidney Disease: Improving Global Outcomes" (KDIGO)
Controversies Conference. Kidney Int. 2017;91:539–551.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27989322</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>de Holanda MI, Pôrto LC, Wagner T, Christiani LF, Palma LMP. Use of
eculizumab in a systemic lupus erythemathosus patient presenting thrombotic
microangiopathy and heterozygous deletion in CFHR1-CFHR3. A case report and
systematic review. Clin Rheumatol 2017;36:2859-67.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28905254</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>de Holanda MI, Pôrto LC, Wagner T, Christiani LF, Palma LMP. Use of eculizumab in a systemic lupus erythemathosus patient
presenting thrombotic microangiopathy and heterozygous deletion in
CFHR1-CFHR3. A case report and systematic review. Clin Rheumatol. 2017;36:2859–2867.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28905254</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bomback AS, Markowitz GS. Lupus Podocytopathy: A Distinct Entity.
Clin J Am Soc Nephrol 2016;11:547-8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4822655</ArticleId>
            <ArticleId IdType="pubmed">26983708</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bomback AS, Markowitz GS. Lupus Podocytopathy: A Distinct Entity. Clin J Am Soc Nephrol. 2016;11:547–548.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4822655</ArticleId>
            <ArticleId IdType="pubmed">26983708</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yu F, Haas M, Glassock R, Zhao MH. Redefining lupus nephritis:
clinical implications of pathophysiologic subtypes. Nat Rev Nephrol
2017;13:483-95.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28669995</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yu F, Haas M, Glassock R, Zhao MH. Redefining lupus nephritis: clinical implications of
pathophysiologic subtypes. Nat Rev Nephrol. 2017;13:483–495.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28669995</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nasr SH, D'Agati VD, Park HR, Sterman PL, Goyzueta JD, Dressler RM,
et al. Necrotizing and crescentic lupus nephritis with antineutrophil
cytoplasmic antibody seropositivity. Clin J Am Soc Nephrol
2008;3:682-90.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2386714</ArticleId>
            <ArticleId IdType="pubmed">18287252</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nasr SH, D'Agati VD, Park HR, Sterman PL, Goyzueta JD, Dressler RM, et al.  Necrotizing and crescentic lupus nephritis with antineutrophil
cytoplasmic antibody seropositivity. Clin J Am Soc Nephrol. 2008;3:682–690.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2386714</ArticleId>
            <ArticleId IdType="pubmed">18287252</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kettritz R. Vasculitis: A CLEAR argument for targeting complement in
ANCA vasculitis. Nature Rev Nephrol 2017;13:448-50.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28529340</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kettritz R. Vasculitis: A CLEAR argument for targeting complement in ANCA
vasculitis. Nature Rev Nephrol. 2017;13:448–450.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28529340</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Austin HA 3rd, Klippel JH, Balow JE, le Riche NG, Steinberg AD,
Plotz PH, et al. Therapy of lupus nephritis. Controlled trial of prednisone and
cytotoxic drugs. New Engl J Med 1986;314:614-9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">3511372</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Austin HA 3rd, Klippel JH, Balow JE, le Riche NG, Steinberg AD, Plotz PH, et al.  Therapy of lupus nephritis. Controlled trial of prednisone and
cytotoxic drugs. New Engl J Med. 1986;314:614–619.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">3511372</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Groot N, de Graeff N, Marks SD, Brogan P, Avcin T, Bader-Meunier B,
et al. European evidence-based recommendations for the diagnosis and treatment
of childhood-onset lupus nephritis: the SHARE initiative. Ann Rheum Dis
2017;76:1965-73.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28877866</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Groot N, de Graeff N, Marks SD, Brogan P, Avcin T, Bader-Meunier B, et al.  European evidence-based recommendations for the diagnosis and
treatment of childhood-onset lupus nephritis: the SHARE
initiative. Ann Rheum Dis. 2017;76:1965–1973.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28877866</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ruiz-Irastorza G, Ramos-Casals M, Brito-Zeron P, Khamashta MA.
Clinical efficacy and side effects of antimalarials in systemic lupus
erythematosus: a systematic review. Ann Rheum Dis 2010;69:20-8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19103632</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ruiz-Irastorza G, Ramos-Casals M, Brito-Zeron P, Khamashta MA. Clinical efficacy and side effects of antimalarials in systemic
lupus erythematosus: a systematic review. Ann Rheum Dis. 2010;69:20–28.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19103632</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Appel GB, Contreras G, Dooley MA, Ginzler EM, Isenberg D, Jayne D,
et al.; Aspreva Lupus Management Study Group. Mycophenolate Mofetil versus
Cyclophosphamide for induction treatment of Lupus Nephritis. J Am Soc Nephrol
2009;20:1103-12.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2678035</ArticleId>
            <ArticleId IdType="pubmed">19369404</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Appel GB, Contreras G, Dooley MA, Ginzler EM, Isenberg D, Jayne D, et al. Aspreva Lupus Management Study Group  Mycophenolate Mofetil versus Cyclophosphamide for induction
treatment of Lupus Nephritis. J Am Soc Nephrol. 2009;20:1103–1112.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2678035</ArticleId>
            <ArticleId IdType="pubmed">19369404</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Houssiau FA, D'Cruz D, Sangle S, Remy P, Vasconcelos C, Petrovic R,
et al.; MAINTAIN Nephritis Trial Group. Azathioprine versus mycophenolate
mofetil for long-term immunosuppression in lupus nephritis: results from the
MAINTAIN Nephritis Trial. Ann Rheum Dis 2010;69:2083-9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3002764</ArticleId>
            <ArticleId IdType="pubmed">20833738</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Houssiau FA, D'Cruz D, Sangle S, Remy P, Vasconcelos C, Petrovic R, et al. MAINTAIN Nephritis Trial Group  Azathioprine versus mycophenolate mofetil for long-term
immunosuppression in lupus nephritis: results from the MAINTAIN Nephritis
Trial. Ann Rheum Dis. 2010;69:2083–2089.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3002764</ArticleId>
            <ArticleId IdType="pubmed">20833738</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dooley MA, Jayne D, Ginzler EM, Isenberg D, Olsen NJ, Wofsy D, et
al.; ALMS Group. Mycophenolate versus Azathioprine as Maintenance Therapy for
Lupus Nephritis. New Engl J Med 2011;365:1886-95.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22087680</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dooley MA, Jayne D, Ginzler EM, Isenberg D, Olsen NJ, Wofsy D, et al. ALMS Group  Mycophenolate versus Azathioprine as Maintenance Therapy for
Lupus Nephritis. New Engl J Med. 2011;365:1886–1895.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22087680</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jennette JC, Iskandar SS, Dalldorf FG. Pathologic differentiation
between lupus and nonlupus membranous glomerulopathy. Kidney Int
1983;24:377-85.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">6358633</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jennette JC, Iskandar SS, Dalldorf FG. Pathologic differentiation between lupus and nonlupus membranous
glomerulopathy. Kidney Int. 1983;24:377–385.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">6358633</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
